Literature DB >> 20958087

Highly enantioselective mukaiyama aldol reactions catalyzed by a chiral oxazaborolidinium ion: total synthesis of (-)-inthomycin C.

Bidyut Kumar Senapati1, Lizhu Gao, Sung Il Lee, Geum-Sook Hwang, Do Hyun Ryu.   

Abstract

A cationic oxazaborolidinium-catalyzed asymmetric Mukaiyama aldol reaction of (1-methoxy-2-methyl-propenyloxy)-trimethylsilane with various aldehydes including α,β-disubstituted acroleins has been developed in high yields and enantioselectivities. The synthetic utility of this methodology was demonstrated in the first short synthesis of naturally occurring inthomycin C in high enantiopurity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20958087     DOI: 10.1021/ol102234k

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

Review 1.  The oxazolomycin family: a review of current knowledge.

Authors:  Patrik Oleksak; Jozef Gonda; Eugenie Nepovimova; Kamil Kuca; Kamil Musilek
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

2.  Stereoselective synthesis of dienyl-carboxylate building blocks: formal synthesis of inthomycin C.

Authors:  Caroline Souris; Frédéric Frébault; Ashay Patel; Davide Audisio; K N Houk; Nuno Maulide
Journal:  Org Lett       Date:  2013-06-13       Impact factor: 6.005

Review 3.  Progress in the total synthesis of inthomycins.

Authors:  Bidyut Kumar Senapati
Journal:  Beilstein J Org Chem       Date:  2021-01-07       Impact factor: 2.883

4.  Short, Tin-Free Synthesis of All Three Inthomycins.

Authors:  Manjeet Kumar; Liam Bromhead; Zoe Anderson; Alistair Overy; Jonathan W Burton
Journal:  Chemistry       Date:  2018-10-19       Impact factor: 5.236

5.  Kinetic resolution of racemic allylic alcohols via iridium-catalyzed asymmetric hydrogenation: scope, synthetic applications and insight into the origin of selectivity.

Authors:  Haibo Wu; Cristiana Margarita; Jira Jongcharoenkamol; Mark D Nolan; Thishana Singh; Pher G Andersson
Journal:  Chem Sci       Date:  2020-12-08       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.